Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionCapital Fund Management S.a.
Latest Disclosed Ownership549,373 shares
Latest Disclosed Value $ 20,189,457
Capital Fund Management S.a. ownership in NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 14, 2026 - Capital Fund Management S.a. filed a 13F-HR form disclosing ownership of 549,373 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $17,332,718 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 136,202 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 303.35% during the quarter. The current value of the position is $19,678,541 USD.

Capital Fund Management S.a. has a history of taking positions in derivatives of the underlying security (NOVA) in the form of stock options. The firm currently holds call options representing 228,800 of underlying shares valued at $8,408,400 USD and put options representing 81,500 of underlying shares valued at $2,995,125 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVO-NORDISK A S ADR NOVO-NORDISK A S ADR 670100205 549,373 413,171 303.35 20,189 191.37 0.0913
2026-02-17 2025-12-31 13F NOVO-NORDISK A S ADR NOVO-NORDISK A S ADR 670100205 136,202 -98,540 -41.98 6,930 -46.80 0.0193
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 234,742 234,742 13,026 0.0341
2025-08-13 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 0 -741,731 -100.00 0 -100.00
2025-05-14 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 741,731 17,381 2.40 51,506 -17.34 0.1486
2025-02-13 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 724,350 237,950 48.92 62,309 7.59 0.1590
2024-11-13 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 486,400 65,390 15.53 57,916 -3.63 0.1585
2024-08-13 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 421,010 -348,006 -45.25 60,095 -39.14 0.1767
2024-05-15 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 769,016 243,565 46.35 98,742 81.65 0.2858
2024-02-14 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 525,451 310,478 144.43 54,358 178.06 0.1461
2023-11-14 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 214,973 214,973 19,550 0.0676
2023-02-13 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 0 -11,189 -100.00 0 -100.00
2022-11-14 2022-09-30 13F NOVO-NORDISK A S ADR 670100205 11,189 -26,976 -70.68 1,115 -73.80 0.0088
2022-08-12 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 38,165 27,925 272.71 4,253 273.97 0.0387
2022-05-12 2022-03-31 13F NOVO-NORDISK A S ADR 670100205 10,240 10,240 1,137 0.0093
2022-02-10 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 0 -12,760 -100.00 0 -100.00
2021-11-12 2021-09-30 13F NOVO-NORDISK A S ADR 670100205 12,760 313 2.51 1,225 17.56 0.0091
2021-08-12 2021-06-30 13F NOVO-NORDISK A S ADR 670100205 12,447 -305 -2.39 1,043 21.30 0.0083
2021-05-14 2021-03-31 13F NOVO-NORDISK A S ADR 670100205 12,752 -200 -1.54 860 -4.98 0.0095
2021-02-12 2020-12-31 13F NOVO-NORDISK A S ADR 670100205 12,952 -12,067 -48.23 905 -47.96 0.0085
2020-11-13 2020-09-30 13F NOVO-NORDISK A S ADR 670100205 25,019 -1,963 -7.28 1,737 -1.64 0.0215
2020-08-13 2020-06-30 13F NOVO-NORDISK A S ADR 670100205 26,982 -123,882 -82.12 1,767 -80.55 0.0280
2020-05-13 2020-03-31 13F Novo Nordisk A ADR 670100205 150,864 -27,730 -15.53 9,082 -12.14 0.1405
2020-02-13 2019-12-31 13F Novo Nordisk A ADR 670100205 178,594 -62,915 -26.05 10,337 -17.21 0.0813
2019-11-13 2019-09-30 13F Novo Nordisk A ADR 670100205 241,509 -169,765 -41.28 12,486 -40.52 0.1124
2019-08-12 2019-06-30 13F Novo Nordisk A ADR 670100205 411,274 -108,304 -20.84 20,991 -22.77 0.1910
2019-05-13 2019-03-31 13F/A-1 Novo Nordisk A ADR 670100205 519,578 -78,690 -13.15 27,179 -1.39 0.2431
2019-05-13 2019-03-31 13F Novo Nordisk A ADR 670100205 598,268 0 27,562
2019-02-13 2018-12-31 13F Novo Nordisk A ADR 670100205 598,268 26,360 4.61 27,562 2.23 0.2439
2018-11-14 2018-09-30 13F Novo Nordisk A ADR 670100205 571,908 116,747 25.65 26,960 28.43 0.1470
2018-08-14 2018-06-30 13F Novo Nordisk A ADR 670100205 455,161 74,787 19.66 20,992 12.06 0.1095
2018-05-15 2018-03-31 13F Novo Nordisk A ADR 670100205 380,374 -34,962 -8.42 18,733 -15.96 0.1124
2018-02-09 2017-12-31 13F Novo Nordisk A ADR 670100205 415,336 195,151 88.63 22,291 110.25 0.1229
2017-11-13 2017-09-30 13F Novo Nordisk A ADR 670100205 220,185 8,507 4.02 10,602 16.77 0.0762
2017-08-10 2017-06-30 13F Novo Nordisk A ADR 670100205 211,678 124,983 144.16 9,079 205.48 0.0732
2017-05-03 2017-03-31 13F Novo Nordisk A ADR 670100205 86,695 -444,293 -83.67 2,972 -84.39 0.0248
2017-02-08 2016-12-31 13F Novo Nordisk A ADR 670100205 530,988 351,169 195.29 19,041 154.59 0.1640
2016-10-31 2016-09-30 13F Novo Nordisk A ADR 670100205 179,819 159,212 772.61 7,479 575.00 0.0687
2016-07-27 2016-06-30 13F Novo Nordisk A ADR 670100205 20,607 -5,187 -20.11 1,108 -20.74 0.0104
2016-05-02 2016-03-31 13F Novo Nordisk A ADR 670100205 25,794 25,794 0.00 1,398 0.0136
2015-07-28 2015-06-30 13F Novo Nordisk A ADR 670100205 0 -123,614 -100.00 0 -100.00
2015-04-28 2015-03-31 13F Novo Nordisk A ADR 670100205 123,614 123,614 0.00 6,600 0.0900
2014-10-31 2014-09-30 13F Novo Nordisk A ADR 670100205 0 -11,436 -100.00 0 -100.00
2014-08-01 2014-06-30 13F Novo Nordisk A ADR 670100205 11,436 -20,404 -64.08 528 -91.02 0.0056
2014-01-31 2013-12-31 13F Novo Nordisk A ADR 670100205 31,840 -19,551 -38.04 5,883 -26.13 0.0728
2013-07-31 2013-06-30 13F Novo Nordisk A ADR 670100205 51,391 51,391 7,964 0.1216
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F NOVO-NORDISK A S ADR NOVO-NORDISK A S ADR Call 228,800 -57.78 8,408 -69.50 n/a n/a n/a
2026-02-17 2025-12-31 13F NOVO-NORDISK A S ADR NOVO-NORDISK A S ADR Call 541,900 -21.17 27,572 -27.72 n/a n/a n/a
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR Call 687,400 8.94 38,144 -12.42 n/a n/a n/a
2025-08-13 2025-06-30 13F NOVO-NORDISK A S ADR Call 631,000 -26.69 43,552 -27.13 n/a n/a n/a
2025-05-14 2025-03-31 13F NOVO-NORDISK A S ADR Call 860,700 180.18 59,767 126.18 n/a n/a n/a
2025-02-13 2024-12-31 13F NOVO-NORDISK A S ADR Call 307,200 74.74 26,425 26.24 n/a n/a n/a
2024-11-13 2024-09-30 13F NOVO-NORDISK A S ADR Call 175,800 51.16 20,933 26.10 n/a n/a n/a
2024-08-13 2024-06-30 13F NOVO-NORDISK A S ADR Call 116,300 54.45 16,601 71.70 n/a n/a n/a
2024-05-15 2024-03-31 13F NOVO-NORDISK A S ADR Call 75,300 -83.12 9,669 -79.06 n/a n/a n/a
2024-02-14 2023-12-31 13F NOVO-NORDISK A S ADR Call 446,200 1,699.19 46,159 1,946.96 n/a n/a n/a
2023-11-14 2023-09-30 13F NOVO-NORDISK A S ADR Call 24,800 2,255 n/a n/a n/a
2022-02-10 2021-12-31 13F NOVO-NORDISK A S ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F NOVO-NORDISK A S ADR Call 29,900 2,871 n/a n/a n/a
2018-11-14 2018-09-30 13F Novo Nordisk A ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F Novo Nordisk A ADR Call 6,800 -67.15 314 -69.19 n/a n/a n/a
2018-05-15 2018-03-31 13F Novo Nordisk A ADR Call 20,700 1,019 n/a n/a n/a
2018-02-09 2017-12-31 13F Novo Nordisk A ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-13 2017-09-30 13F Novo Nordisk A ADR Call 10,300 496 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F NOVO-NORDISK A S ADR NOVO-NORDISK A S ADR Put 81,500 -21.79 2,995 -43.50 n/a n/a n/a
2026-02-17 2025-12-31 13F NOVO-NORDISK A S ADR NOVO-NORDISK A S ADR Put 104,200 -77.02 5,302 -78.93 n/a n/a n/a
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR Put 453,400 -0.04 25,159 -19.64 n/a n/a n/a
2025-08-13 2025-06-30 13F NOVO-NORDISK A S ADR Put 453,600 -8.59 31,307 -9.14 n/a n/a n/a
2025-05-14 2025-03-31 13F NOVO-NORDISK A S ADR Put 496,200 73.68 34,456 40.21 n/a n/a n/a
2025-02-13 2024-12-31 13F NOVO-NORDISK A S ADR Put 285,700 -19.70 24,576 -41.99 n/a n/a n/a
2024-11-13 2024-09-30 13F NOVO-NORDISK A S ADR Put 355,800 5.11 42,365 -12.32 n/a n/a n/a
2024-08-13 2024-06-30 13F NOVO-NORDISK A S ADR Put 338,500 145.11 48,317 172.48 n/a n/a n/a
2024-05-15 2024-03-31 13F NOVO-NORDISK A S ADR Put 138,100 -60.42 17,732 -50.87 n/a n/a n/a
2024-02-14 2023-12-31 13F NOVO-NORDISK A S ADR Put 348,900 573.55 36,094 666.31 n/a n/a n/a
2023-11-14 2023-09-30 13F NOVO-NORDISK A S ADR Put 51,800 4,711 n/a n/a n/a
2022-05-12 2022-03-31 13F NOVO-NORDISK A S ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-10 2021-12-31 13F NOVO-NORDISK A S ADR Put 21,800 -20.44 2,442 -7.19 n/a n/a n/a
2021-11-12 2021-09-30 13F NOVO-NORDISK A S ADR Put 27,400 2,631 n/a n/a n/a
2018-08-14 2018-06-30 13F Novo Nordisk A ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F Novo Nordisk A ADR Put 7,600 374 n/a n/a n/a
2018-02-09 2017-12-31 13F Novo Nordisk A ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-13 2017-09-30 13F Novo Nordisk A ADR Put 8,100 390 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.